Science ❯ Biotechnology ❯ Pharmaceuticals ❯ Drug Delivery Systems
Targeting the transferrin receptor with Fc-modified ATVcisLALA achieves a five- to eight-fold boost in brain antibody levels, minimizing vascular inflammation.
